Association between regulator of G protein signaling 9-2 and body weight

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Waugh, Jeffrey L ^a   Celver, Jeremy ^b,c   Sharma, Meenakshi ^b   Dufresne, Robert L ^b   Terzi, Dimitra ^d   Risch, S Craig ^e   Fairbrother, William G ^f   Neve, Rachael L ^g   Kane, John P ^e,h   Malloy, Mary J ^e   Pullinger, Clive R ^e   Gu, Harvest F ⁱ   Tsatsanis, Christos ^d   Hamilton, Steven P ^e   Gold, Stephen J ^a   Zachariou, Venetia ^d   Kovoor, Abraham ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c Kovogen LLC   (United States)

^d UNIVERSITY OF CRETE   (Greece)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BROWN UNIVERSITY   (United States)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RGS PROTEIN; RGS11 PROTEIN; RGS7 PROTEIN; RGS9-2 PROTEIN; RNA; UNCLASSIFIED DRUG; REGULATOR OF G PROTEIN SIGNALING 9; REGULATOR OF G-PROTEIN SIGNALING 9;

ABDOMINAL FAT; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE; CONTROLLED STUDY; EAST ASIAN; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FOOD INTAKE; GENE; GENE DELETION; GENE OVEREXPRESSION; HUMAN; JAPANESE; KNOCKOUT MOUSE; KOREAN; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PACIFIC ISLANDER; RAT; REPORTER GENE; RGS9 GENE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIAN; STRAIN DIFFERENCE; WEIGHT CONTROL; WEIGHT REDUCTION; WILD TYPE; ADIPOSE TISSUE; ANIMAL; GENETIC ASSOCIATION; GENETICS; INTRAABDOMINAL FAT; INTRON; METABOLISM; MOLECULAR GENETICS; MOTOR ACTIVITY; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY;

MUS; RATTUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; BODY MASS INDEX; BODY WEIGHT; FEMALE; GENES, REPORTER; GENETIC ASSOCIATION STUDIES; HUMANS; INTRA-ABDOMINAL FAT; INTRONS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RGS PROTEINS; RNA SPLICING; SEQUENCE DELETION; WEIGHT LOSS;

EID: 81755184063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027984     Document Type: Article

References (67)

1. Bodnar RJ, (2004) Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25: 697-725.
2. Gainetdinov RR, (2007) Mesolimbic dopamine in obesity and diabetes. Am J Physiol Regul Integr Comp Physiol 293: R601-602.
3. Willars GB, (2006) Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin Cell Dev Biol 17: 363-376.
4. Sethakorn N, Yau DM, Dulin NO, (2010) Non-canonical functions of RGS proteins. Cell Signal 22: 1274-1281.
5. Rahman Z, Gold SJ, Potenza MN, Cowan CW, Ni YG, et al. (1999) Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci 19: 2016-2026.
6. Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, et al. (2005) D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci 25: 2157-2165.
7. Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, et al. (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38: 941-952.
8. Celver J, Sharma M, Kovoor A, (2010) RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors. J Neurochem 114: 739-749.
9. Cabrera-Vera TM, Hernandez S, Earls LR, Medkova M, Sundgren-Andersson AK, et al. (2004) RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc Natl Acad Sci U S A 101: 16339-16344. Epub 12004 Nov 16308.
10. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, et al. (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci U S A 100: 13656-13661.
11. Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, et al. (2007) RGS9-2 is a negative modulator of mu-opioid receptor function. J Neurochem 103: 617-625.
12. Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, et al. (2011) A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci 31: 5617-5624.
13. Johnson PM, Kenny PJ, (2010) Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 13: 635-641.
14. Le Merrer J, Becker JA, Befort K, Kieffer BL, (2009) Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
15. Hooks SB, Martemyanov K, Zachariou V, (2008) A role of RGS proteins in drug addiction. Biochem Pharmacol 75: 76-84.
16. Thomas EA, Danielson PE, Sutcliffe JG, (1998) RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum. J Neurosci Res 52: 118-124.
17. Zhang K, Howes KA, He W, Bronson JD, Pettenati MJ, et al. (1999) Structure, alternative splicing, and expression of the human RGS9 gene. Gene 240: 23-34.
18. Anderson GR, Posokhova E, Martemyanov KA, (2009) The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling. Cell Biochem Biophys 54: 33-46.
19. Reid DC, Chang BL, Gunderson SI, Alpert L, Thompson WA, et al. (2009) Next-generation SELEX identifies sequence and structural determinants of splicing factor binding in human pre-mRNA sequence. RNA 15: 2385-2397.
20. Sawicka K, Bushell M, Spriggs KA, Willis AE, (2008) Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans 36: 641-647.
21. Cooper TA, (2005) Use of minigene systems to dissect alternative splicing elements. Methods 37: 331-340.
22. Gaildrat P, Killian A, Martins A, Tournier I, Frebourg T, et al. (2010) Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol 653: 249-257.
23. Martemyanov KA, Yoo PJ, Skiba NP, Arshavsky VY, (2005) R7BP, a novel neuronal protein interacting with RGS proteins of the R7 family. J Biol Chem 280: 5133-5136. Epub 2005 Jan 5134.
24. Gold SJ, Hoang CV, Potts BW, Porras G, Pioli E, et al. (2007) RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J Neurosci 27: 14338-14348.
25. World Health Organization Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
26. Su B, Jin L, Underhill P, Martinson J, Saha N, et al. (2000) Polynesian origins: insights from the Y chromosome. Proc Natl Acad Sci U S A 97: 8225-8228.
27. Soares P, Rito T, Trejaut J, Mormina M, Hill C, et al. (2011) Ancient voyaging and Polynesian origins. Am J Hum Genet 88: 239-247.
28. Graybiel AM, (2000) The basal ganglia. Curr Biol 10: R509-511.
29. Cao Y, Masuho I, Okawa H, Xie K, Asami J, et al. (2009) Retina-specific GTPase accelerator RGS11/G beta 5S/R9AP is a constitutive heterotrimer selectively targeted to mGluR6 in ON-bipolar neurons. J Neurosci 29: 9301-9313.
30. Masuho I, Celver J, Kovoor A, Martemyanov KA, (2010) Membrane anchor R9AP potentiates GTPase-accelerating protein activity of RGS11×Gbeta5 complex and accelerates inactivation of the mGluR6-G(o) signaling. J Biol Chem 285: 4781-4787.
31. Keresztes G, Martemyanov KA, Krispel CM, Mutai H, Yoo PJ, et al. (2004) Absence of the RGS9.Gbeta5 GTPase-activating complex in photoreceptors of the R9AP knockout mouse. J Biol Chem 279: 1581-1584.
32. Chen CK, Eversole-Cire P, Zhang H, Mancino V, Chen YJ, et al. (2003) Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc Natl Acad Sci U S A 100: 6604-6609.
33. Song JH, Song H, Wensel TG, Sokolov M, Martemyanov KA, (2007) Localization and differential interaction of R7 RGS proteins with their membrane anchors R7BP and R9AP in neurons of vertebrate retina. Mol Cell Neurosci 35: 311-319.
34. Anderson GR, Cao Y, Davidson S, Truong HV, Pravetoni M, et al. (2010) R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine. Neuropsychopharmacology 35: 1040-1050.
35. Laroche G, Giguere PM, Roth BL, Trejo J, Siderovski DP, (2010) RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signaling. Am J Physiol Cell Physiol 299: C654-664.
36. Agenes F, Bosco N, Mascarell L, Fritah S, Ceredig R, (2005) Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology 115: 179-188.
37. Jayaraman M, Zhou H, Jia L, Cain MD, Blumer KJ, (2009) R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling. Trends Pharmacol Sci 30: 17-24.
38. Gold SJ, Ni YG, Dohlman HG, Nestler EJ, (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037.
39. Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG, (2011) The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 1350: 43-64.
40. Bubser M, Fadel JR, Jackson LL, Meador-Woodruff JH, Jing D, et al. (2005) Dopaminergic regulation of orexin neurons. Eur J Neurosci 21: 2993-3001.
41. Baldo BA, Daniel RA, Berridge CW, Kelley AE, (2003) Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464: 220-237.
42. Saito Y, Cheng M, Leslie FM, Civelli O, (2001) Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 435: 26-40.
43. Kelley AE, Baldo BA, Pratt WE, Will MJ, (2005) Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav 86: 773-795.
44. Aissani B, Perusse L, Lapointe G, Chagnon YC, Bouchard L, et al. (2006) A quantitative trait locus for body fat on chromosome 1q43 in French Canadians: linkage and association studies. Obesity (Silver Spring) 14: 1605-1615.
45. Posokhova E, Wydeven N, Allen KL, Wickman K, Martemyanov KA, (2010) RGS6/Gss5 complex accelerates IKACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Circ Res 107: 1350-1354.
46. Yang J, Huang J, Maity B, Gao Z, Lorca RA, et al. (2010) RGS6, a modulator of parasympathetic activation in heart. Circ Res 107: 1345-1349.
47. Wang Q, Levay K, Chanturiya T, Dvoriantchikova G, Anderson KL, et al. (2011) Targeted deletion of one or two copies of the G protein {beta} subunit G{beta}5 gene has distinct effects on body weight and behavior in mice. FASEB J.
48. Pacey LK, Doss L, Cifelli C, van der Kooy D, Heximer SP, et al. (2011) Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse. Mol Cell Neurosci 46: 563-572.
49. Cho H, Park C, Hwang IY, Han SB, Schimel D, et al. (2008) Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28: 2590-2597.
50. Nunn C, Zhao P, Zou MX, Summers K, Guglielmo CG, et al. (2011) Resistance to age-related, normal body weight gain in RGS2 deficient mice. Cell Signal 23: 1375-1386.
51. Sartori M, Ceolotto G, Dorigatti F, Mos L, Santonastaso M, et al. (2008) RGS2 C1114G polymorphism and body weight gain in hypertensive patients. Metabolism 57: 421-427.
52. Bansal G, Druey KM, Xie Z, (2007) R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 116: 473-495.
53. Huang X, Charbeneau RA, Fu Y, Kaur K, Gerin I, et al. (2008) Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes 57: 77-85.
54. Shiffman D, Ellis SG, Rowland CM, Malloy MJ, Luke MM, et al. (2005) Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77: 596-605.
55. Pullinger CR, Aouizerat BE, Movsesyan I, Durlach V, Sijbrands EJ, et al. (2008) An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J Lipid Res 49: 1846-1854.
56. Toonen RJ, Hughes S, (2001) Increased throughput for fragment analysis on an ABI PRISM 377 automated sequencer using a membrane comb and STRand software. Biotechniques 31: 1320-1324.
57. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, et al. (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119: 831-845.
58. Chen CK, Burns ME, He W, Wensel TG, Baylor DA, et al. (2000) Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 403: 557-560.
59. Kiernan J, (2008) Histological and Histochemical Methods: Theory and Practice. Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press.
60. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, et al. (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277: 812-814.
61. Carlezon WA Jr, Nestler EJ, Neve RL, (2000) Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol 14: 47-67.
62. Coopersmith R, Neve RL, (1999) Expression of multiple proteins within single primary cortical neurons using a replication deficient HSV vector. Biotechniques 27: 1156-1160.
63. Kalivas PW, Duffy P, (1990) Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58.
64. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, et al. (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci 22: 3293-3301.
65. Uhl GR, Hall FS, Sora I, (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7: 21-26.
66. Paxinos G, Watson C, (1986) The Rat Brain in Stereotaxic Coordinates. San Diego, CA Academic Press.
67. Neve RL, Neve KA, Nestler EJ, Carlezon WA Jr, (2005) Use of herpes virus amplicon vectors to study brain disorders. Biotechniques 39: 381-391.